Dive Brief:
- Livongo Health named former Cerner president Zane Burke its new CEO Tuesday, marking another splashy leadership hire for the digital chronic care company.
- Current CEO Glen Tullman will take the title of executive chairman. Tullman previously led electronic health record giant Allscripts as CEO. In an interview last week, Tullman told MedTech Dive that Livongo revenue is set to more than double in 2018 to about $61 million.
- The company also promoted Chief Medical Officer Jennifer Schneider to president, where she will oversee aspects of the company's product, data science, software engineering, marketing and clinical operations teams.
Dive Insight:
Burke, who left Cerner in September, played a key role in obtaining the company's $10 billion no-bid contract to replace the Veterans Administration's medical records systems with Cerner's EHR.
Livongo is hopeful Burke will help oversee the company at a time that it is expanding rapidly. According to the Silicon Valley Business Journal, the company's revenues jumped from about $2.1 million in 2015 to more than $30 million in 2017.
Tullman told MedTech Dive in an interview that revenue is set to more than double in 2018 to about $61 million.
The company currently has more than 600 companies enrolled in its programs including Express Scripts and CVS as well as four of the top seven payers, according to Tullman. The exiting CEO said that the company is set to add another 160 companies in January 2019.
Other recent milestones for Livongo include a partnership with Abbott to provide the medical device giant's FreeStyle Libre Pro System to its members with diabetes. And in November, the company received full Centers for Disease Control and Prevention recognition for its diabetes prevention program.
"I think the CDC recognition for our diabetes prevention program is a validation that we're actually driving measurable clinical outcomes for our members," Tullman said. "To get CDC validation, you actually have to demonstrate that you're driving overtime measurable clinical outcomes for your members."
Livongo is moving toward adding more chronic conditions to the company's portfolio, according to Tullman.
"We've already been accelerating the business, adding more conditions, because our goal is to treat the whole person and focus less on any individual category," Tullman said. "How do we empower someone and make it easier for them to stay healthy, giving them a combination of information and the actual devices, supplies, tools, even medication that allow them, that make it simply easier to stay healthy."
Burke said that he will be focusing on leveraging Livongo's position to "appropriately manage the resources consumed in managing" chronic conditions. Livongo also has programs aimed at pre-diabetes, high blood pressure, weight management and medication optimization.
"As we rapidly grow our business and build new capabilities, we are able to aggregate and interpret more data on more conditions, and deliver actionable, personalized and timely health signals to more and more people with chronic conditions empowering them get and stay healthy," Schneider said.
